|
|
|
Volumn 12, Issue 2, 2002, Pages 107-113
|
|
Equivalent efficacy and safety of a new HFA-134a formulation of BDP compared with the conventional CFC in adult asthmatics
a
a
a
a
a
a
a
|
|
Author keywords
BDP; CFC; HFA 134a; Morning serum cortisol
|
|
Indexed keywords
ANTIHISTAMINIC AGENT;
BECLOMETASONE DIPROPIONATE;
BRONCHODILATING AGENT;
CHLOROFLUOROCARBON;
CHOLINERGIC RECEPTOR BLOCKING AGENT;
CORTICOSTEROID;
CROMOGLYCATE DISODIUM;
LEUKOTRIENE RECEPTOR BLOCKING AGENT;
NEDOCROMIL SODIUM;
NORFLURANE;
SALBUTAMOL;
THEOPHYLLINE;
ANDROSTANE DERIVATIVE;
ANTIASTHMATIC AGENT;
ANTIINFLAMMATORY AGENT;
BECLOMETASONE;
BUDESONIDE;
FLUORINATED HYDROCARBON;
FLUTICASONE;
ADULT;
AGED;
ARTICLE;
ASTHMA;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
COUGHING;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
DRUG FORMULATION;
DRUG SAFETY;
FEMALE;
HUMAN;
LUNG FUNCTION TEST;
MAJOR CLINICAL STUDY;
MALE;
METERED DOSE INHALER;
MULTICENTER STUDY;
PEAK EXPIRATORY FLOW;
RANDOMIZED CONTROLLED TRIAL;
THRUSH;
XEROSTOMIA;
CHEMISTRY;
COMPARATIVE STUDY;
DRUG EFFECT;
FORCED EXPIRATORY VOLUME;
HOSPITALIZATION;
MIDDLE AGED;
PATIENT COMPLIANCE;
REGRESSION ANALYSIS;
TREATMENT OUTCOME;
UNITED KINGDOM;
VITAL CAPACITY;
ADULT;
AGED;
ANDROSTADIENES;
ANTI-ASTHMATIC AGENTS;
ANTI-INFLAMMATORY AGENTS, STEROIDAL;
ASTHMA;
BECLOMETHASONE;
BUDESONIDE;
CHEMISTRY, PHARMACEUTICAL;
CHLOROFLUOROCARBONS;
COMPARATIVE STUDY;
DOUBLE-BLIND METHOD;
FEMALE;
FORCED EXPIRATORY VOLUME;
GREAT BRITAIN;
HUMAN;
HYDROCARBONS, FLUORINATED;
LEAST-SQUARES ANALYSIS;
MALE;
MIDDLE AGE;
PATIENT COMPLIANCE;
PEAK EXPIRATORY FLOW RATE;
SEVERITY OF ILLNESS INDEX;
TREATMENT OUTCOME;
VITAL CAPACITY;
ANTI-INFLAMMATORY AGENTS;
HUMANS;
MIDDLE AGED;
|
|
EID: 0036022877
PISSN: 10189068
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (16)
|
|
References (13)
|
